These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 23940030

  • 1. The F-box protein FBXO25 promotes the proteasome-dependent degradation of ELK-1 protein.
    Teixeira FR, Manfiolli AO, Soares CS, Baqui MM, Koide T, Gomes MD.
    J Biol Chem; 2013 Sep 27; 288(39):28152-62. PubMed ID: 23940030
    [Abstract] [Full Text] [Related]

  • 2. ELK-1 ubiquitination status and transcriptional activity are modulated independently of F-Box protein FBXO25.
    Quintero-Barceinas RS, Gehringer F, Ducker C, Saxton J, Shaw PE.
    J Biol Chem; 2021 Sep 27; 296():100214. PubMed ID: 33428929
    [Abstract] [Full Text] [Related]

  • 3. A novel Fbxo25 acts as an E3 ligase for destructing cardiac specific transcription factors.
    Jang JW, Lee WY, Lee JH, Moon SH, Kim CH, Chung HM.
    Biochem Biophys Res Commun; 2011 Jul 01; 410(2):183-8. PubMed ID: 21596019
    [Abstract] [Full Text] [Related]

  • 4. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
    Spagnol V, Oliveira CAB, Randle SJ, Passos PMS, Correia CRSTB, Simaroli NB, Oliveira JS, Mevissen TET, Medeiros AC, Gomes MD, Komander D, Laman H, Teixeira FR.
    Biochim Biophys Acta Gen Subj; 2021 Jan 01; 1865(1):129754. PubMed ID: 33010352
    [Abstract] [Full Text] [Related]

  • 5. Fbxo25 controls Tbx5 and Nkx2-5 transcriptional activity to regulate cardiomyocyte development.
    Jeong HS, Jung ES, Sim YJ, Kim SJ, Jang JW, Hong KS, Lee WY, Chung HM, Park KT, Jung YS, Kim CH, Kim KS.
    Biochim Biophys Acta; 2015 Jun 01; 1849(6):709-21. PubMed ID: 25725482
    [Abstract] [Full Text] [Related]

  • 6. Identification of FBXO25-interacting proteins using an integrated proteomics approach.
    Teixeira FR, Yokoo S, Gartner CA, Manfiolli AO, Baqui MM, Assmann EM, Maragno AL, Yu H, de Lanerolle P, Kobarg J, Gygi SP, Gomes MD.
    Proteomics; 2010 Aug 01; 10(15):2746-57. PubMed ID: 20473970
    [Abstract] [Full Text] [Related]

  • 7. FBXO25, an F-box protein homologue of atrogin-1, is not induced in atrophying muscle.
    Maragno AL, Baqui MM, Gomes MD.
    Biochim Biophys Acta; 2006 Jun 01; 1760(6):966-72. PubMed ID: 16714087
    [Abstract] [Full Text] [Related]

  • 8. F-box protein Fbxo3 targets Smurf1 ubiquitin ligase for ubiquitination and degradation.
    Li D, Xie P, Zhao F, Shu J, Li L, Zhan Y, Zhang L.
    Biochem Biophys Res Commun; 2015 Mar 20; 458(4):941-5. PubMed ID: 25721664
    [Abstract] [Full Text] [Related]

  • 9. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
    Nakajima T, Kitagawa K, Ohhata T, Sakai S, Uchida C, Shibata K, Minegishi N, Yumimoto K, Nakayama KI, Masumoto K, Katou F, Niida H, Kitagawa M.
    J Biol Chem; 2015 Apr 17; 290(16):10368-81. PubMed ID: 25670854
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. FBXO25-associated nuclear domains: a novel subnuclear structure.
    Manfiolli AO, Maragno AL, Baqui MM, Yokoo S, Teixeira FR, Oliveira EB, Gomes MD.
    Mol Biol Cell; 2008 May 17; 19(5):1848-61. PubMed ID: 18287534
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A new mechanism of RhoA ubiquitination and degradation: roles of SCF(FBXL19) E3 ligase and Erk2.
    Wei J, Mialki RK, Dong S, Khoo A, Mallampalli RK, Zhao Y, Zhao J.
    Biochim Biophys Acta; 2013 Dec 17; 1833(12):2757-2764. PubMed ID: 23871831
    [Abstract] [Full Text] [Related]

  • 15. Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis.
    Baumann U, Fernández-Sáiz V, Rudelius M, Lemeer S, Rad R, Knorn AM, Slawska J, Engel K, Jeremias I, Li Z, Tomiatti V, Illert AL, Targosz BS, Braun M, Perner S, Leitges M, Klapper W, Dreyling M, Miething C, Lenz G, Rosenwald A, Peschel C, Keller U, Kuster B, Bassermann F.
    Nat Med; 2014 Dec 17; 20(12):1401-9. PubMed ID: 25419709
    [Abstract] [Full Text] [Related]

  • 16. Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively.
    Liu J, Dong S, Wang H, Li L, Ye Q, Li Y, Miao J, Jhiang S, Zhao J, Zhao Y.
    FASEB J; 2019 Sep 17; 33(9):10538-10550. PubMed ID: 31238008
    [Abstract] [Full Text] [Related]

  • 17. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.
    Biswas M, Phan D, Watanabe M, Chan JY.
    J Biol Chem; 2011 Nov 11; 286(45):39282-9. PubMed ID: 21953459
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation.
    Han XR, Zha Z, Yuan HX, Feng X, Xia YK, Lei QY, Guan KL, Xiong Y.
    Oncogene; 2016 Aug 11; 35(32):4179-90. PubMed ID: 26725323
    [Abstract] [Full Text] [Related]

  • 20. The super-cooling compound icilin stimulates c-Fos and Egr-1 expression and activity involving TRPM8 channel activation, Ca2+ ion influx and activation of the ternary complex factor Elk-1.
    Ulrich M, Wissenbach U, Thiel G.
    Biochem Pharmacol; 2020 Jul 11; 177():113936. PubMed ID: 32224140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.